Table of Content

1 Influenza Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Influenza Drugs and Vaccines
1.2 Influenza Drugs and Vaccines Segment by Type
1.2.1 Global Influenza Drugs and Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Influenza Drugs and Vaccines Segment by Application
1.3.1 Global Influenza Drugs and Vaccines Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Influenza Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Influenza Drugs and Vaccines Revenue 2018-2029
1.4.2 Global Influenza Drugs and Vaccines Sales 2018-2029
1.4.3 Global Influenza Drugs and Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Influenza Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Influenza Drugs and Vaccines Average Price by Manufacturers (2018-2024)
2.4 Global Influenza Drugs and Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Drugs and Vaccines, Product Type & Application
2.7 Influenza Drugs and Vaccines Market Competitive Situation and Trends
2.7.1 Influenza Drugs and Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Influenza Drugs and Vaccines Players Market Share by Revenue
2.7.3 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Influenza Drugs and Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Influenza Drugs and Vaccines Global Influenza Drugs and Vaccines Sales by Region: 2018-2029
3.2.1 Global Influenza Drugs and Vaccines Sales by Region: 2018-2024
3.2.2 Global Influenza Drugs and Vaccines Sales by Region: 2024-2029
3.3 Global Influenza Drugs and Vaccines Global Influenza Drugs and Vaccines Revenue by Region: 2018-2029
3.3.1 Global Influenza Drugs and Vaccines Revenue by Region: 2018-2024
3.3.2 Global Influenza Drugs and Vaccines Revenue by Region: 2024-2029
3.4 North America Influenza Drugs and Vaccines Market Facts & Figures by Country
3.4.1 North America Influenza Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Influenza Drugs and Vaccines Sales by Country (2018-2029)
3.4.3 North America Influenza Drugs and Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country
3.5.1 Europe Influenza Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Influenza Drugs and Vaccines Sales by Country (2018-2029)
3.5.3 Europe Influenza Drugs and Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Influenza Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Influenza Drugs and Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Influenza Drugs and Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Influenza Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Latin America Influenza Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Influenza Drugs and Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Influenza Drugs and Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Influenza Drugs and Vaccines Sales by Type (2018-2029)
4.1.1 Global Influenza Drugs and Vaccines Sales by Type (2018-2024)
4.1.2 Global Influenza Drugs and Vaccines Sales by Type (2024-2029)
4.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Influenza Drugs and Vaccines Revenue by Type (2018-2029)
4.2.1 Global Influenza Drugs and Vaccines Revenue by Type (2018-2024)
4.2.2 Global Influenza Drugs and Vaccines Revenue by Type (2024-2029)
4.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Influenza Drugs and Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Influenza Drugs and Vaccines Sales by Application (2018-2029)
5.1.1 Global Influenza Drugs and Vaccines Sales by Application (2018-2024)
5.1.2 Global Influenza Drugs and Vaccines Sales by Application (2024-2029)
5.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Influenza Drugs and Vaccines Revenue by Application (2018-2029)
5.2.1 Global Influenza Drugs and Vaccines Revenue by Application (2018-2024)
5.2.2 Global Influenza Drugs and Vaccines Revenue by Application (2024-2029)
5.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Influenza Drugs and Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Bristol Myers Squibb
6.2.1 Bristol Myers Squibb Corporation Information
6.2.2 Bristol Myers Squibb Description and Business Overview
6.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
6.2.5 Bristol Myers Squibb Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Roche Influenza Drugs and Vaccines Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis Influenza Drugs and Vaccines Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Bayer Influenza Drugs and Vaccines Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Influenza Drugs and Vaccines Description and Business Overview
6.11.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Celgene Influenza Drugs and Vaccines Product Portfolio
6.11.5 Celgene Recent Developments/Updates
6.12 Seqirus
6.12.1 Seqirus Corporation Information
6.12.2 Seqirus Influenza Drugs and Vaccines Description and Business Overview
6.12.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
6.12.5 Seqirus Recent Developments/Updates
6.13 Protein Sciences Corporation
6.13.1 Protein Sciences Corporation Corporation Information
6.13.2 Protein Sciences Corporation Influenza Drugs and Vaccines Description and Business Overview
6.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
6.13.5 Protein Sciences Corporation Recent Developments/Updates
6.14 Serum Institute of India
6.14.1 Serum Institute of India Corporation Information
6.14.2 Serum Institute of India Influenza Drugs and Vaccines Description and Business Overview
6.14.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
6.14.5 Serum Institute of India Recent Developments/Updates
6.15 Emergent Biosolutions
6.15.1 Emergent Biosolutions Corporation Information
6.15.2 Emergent Biosolutions Influenza Drugs and Vaccines Description and Business Overview
6.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
6.15.5 Emergent Biosolutions Recent Developments/Updates
6.16 BioCryst Pharmaceuticals
6.16.1 BioCryst Pharmaceuticals Corporation Information
6.16.2 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Description and Business Overview
6.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
6.16.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.17 Alvogen
6.17.1 Alvogen Corporation Information
6.17.2 Alvogen Influenza Drugs and Vaccines Description and Business Overview
6.17.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
6.17.5 Alvogen Recent Developments/Updates
6.18 Viatris
6.18.1 Viatris Corporation Information
6.18.2 Viatris Influenza Drugs and Vaccines Description and Business Overview
6.18.3 Viatris Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Viatris Influenza Drugs and Vaccines Product Portfolio
6.18.5 Viatris Recent Developments/Updates
6.19 Hulan Bio
6.19.1 Hulan Bio Corporation Information
6.19.2 Hulan Bio Influenza Drugs and Vaccines Description and Business Overview
6.19.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
6.19.5 Hulan Bio Recent Developments/Updates
6.20 Changchun Institute of Biological
6.20.1 Changchun Institute of Biological Corporation Information
6.20.2 Changchun Institute of Biological Influenza Drugs and Vaccines Description and Business Overview
6.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
6.20.5 Changchun Institute of Biological Recent Developments/Updates
6.21 Jiangsu GDK
6.21.1 Jiangsu GDK Corporation Information
6.21.2 Jiangsu GDK Influenza Drugs and Vaccines Description and Business Overview
6.21.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
6.21.5 Jiangsu GDK Recent Developments/Updates
6.22 Sinovac
6.22.1 Sinovac Corporation Information
6.22.2 Sinovac Influenza Drugs and Vaccines Description and Business Overview
6.22.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
6.22.5 Sinovac Recent Developments/Updates
6.23 Beike Bio
6.23.1 Beike Bio Corporation Information
6.23.2 Beike Bio Influenza Drugs and Vaccines Description and Business Overview
6.23.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
6.23.5 Beike Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Drugs and Vaccines Industry Chain Analysis
7.2 Influenza Drugs and Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Drugs and Vaccines Production Mode & Process
7.4 Influenza Drugs and Vaccines Sales and Marketing
7.4.1 Influenza Drugs and Vaccines Sales Channels
7.4.2 Influenza Drugs and Vaccines Distributors
7.5 Influenza Drugs and Vaccines Customers
8 Influenza Drugs and Vaccines Market Dynamics
8.1 Influenza Drugs and Vaccines Industry Trends
8.2 Influenza Drugs and Vaccines Market Drivers
8.3 Influenza Drugs and Vaccines Market Challenges
8.4 Influenza Drugs and Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Influenza Drugs and Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Influenza Drugs and Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Influenza Drugs and Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Influenza Drugs and Vaccines Sales (Tons) of Key Manufacturers (2018-2024)
Table 5. Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Influenza Drugs and Vaccines Average Price (US$/Kg) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Influenza Drugs and Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Influenza Drugs and Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Influenza Drugs and Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Influenza Drugs and Vaccines Sales by Region (2018-2024) & (Tons)
Table 18. Global Influenza Drugs and Vaccines Sales Market Share by Region (2018-2024)
Table 19. Global Influenza Drugs and Vaccines Sales by Region (2024-2029) & (Tons)
Table 20. Global Influenza Drugs and Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Influenza Drugs and Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2018-2024)
Table 23. Global Influenza Drugs and Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 27. North America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 28. North America Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 32. Europe Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 33. Europe Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Influenza Drugs and Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2018-2024) & (Tons)
Table 37. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 42. Latin America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 47. Middle East & Africa Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Influenza Drugs and Vaccines Sales (Tons) by Type (2018-2024)
Table 51. Global Influenza Drugs and Vaccines Sales (Tons) by Type (2024-2029)
Table 52. Global Influenza Drugs and Vaccines Sales Market Share by Type (2018-2024)
Table 53. Global Influenza Drugs and Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2024)
Table 57. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2018-2024)
Table 59. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2024-2029)
Table 60. Global Influenza Drugs and Vaccines Sales (Tons) by Application (2018-2024)
Table 61. Global Influenza Drugs and Vaccines Sales (Tons) by Application (2024-2029)
Table 62. Global Influenza Drugs and Vaccines Sales Market Share by Application (2018-2024)
Table 63. Global Influenza Drugs and Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2024)
Table 67. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2018-2024)
Table 69. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2024-2029)
Table 70. CSL Corporation Information
Table 71. CSL Description and Business Overview
Table 72. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 73. CSL Influenza Drugs and Vaccines Product
Table 74. CSL Recent Developments/Updates
Table 75. Bristol Myers Squibb Corporation Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 78. Bristol Myers Squibb Influenza Drugs and Vaccines Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 83. AstraZeneca Influenza Drugs and Vaccines Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 88. Eli Lilly Influenza Drugs and Vaccines Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 93. Roche Influenza Drugs and Vaccines Product
Table 94. Roche Recent Developments/Updates
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 98. GlaxoSmithKline Influenza Drugs and Vaccines Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 103. Novartis Influenza Drugs and Vaccines Product
Table 104. Novartis Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 108. Pfizer Influenza Drugs and Vaccines Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 113. Sanofi Influenza Drugs and Vaccines Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 118. Bayer Influenza Drugs and Vaccines Product
Table 119. Bayer Recent Developments/Updates
Table 120. Celgene Corporation Information
Table 121. Celgene Description and Business Overview
Table 122. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 123. Celgene Influenza Drugs and Vaccines Product
Table 124. Celgene Recent Developments/Updates
Table 125. Seqirus Corporation Information
Table 126. Seqirus Description and Business Overview
Table 127. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 128. Seqirus Influenza Drugs and Vaccines Product
Table 129. Seqirus Recent Developments/Updates
Table 130. Protein Sciences Corporation Corporation Information
Table 131. Protein Sciences Corporation Description and Business Overview
Table 132. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 133. Protein Sciences Corporation Influenza Drugs and Vaccines Product
Table 134. Protein Sciences Corporation Recent Developments/Updates
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Business Overview
Table 137. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 138. Serum Institute of India Influenza Drugs and Vaccines Product
Table 139. Serum Institute of India Recent Developments/Updates
Table 140. Emergent Biosolutions Corporation Information
Table 141. Emergent Biosolutions Description and Business Overview
Table 142. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 143. Emergent Biosolutions Influenza Drugs and Vaccines Product
Table 144. Emergent Biosolutions Recent Developments/Updates
Table 145. BioCryst Pharmaceuticals Corporation Information
Table 146. BioCryst Pharmaceuticals Description and Business Overview
Table 147. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 148. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product
Table 149. BioCryst Pharmaceuticals Recent Developments/Updates
Table 150. Alvogen Corporation Information
Table 151. Alvogen Description and Business Overview
Table 152. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 153. Alvogen Influenza Drugs and Vaccines Product
Table 154. Alvogen Recent Developments/Updates
Table 155. Viatris Corporation Information
Table 156. Viatris Description and Business Overview
Table 157. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 158. Viatris Influenza Drugs and Vaccines Product
Table 159. Viatris Recent Developments/Updates
Table 160. Hulan Bio Corporation Information
Table 161. Hulan Bio Description and Business Overview
Table 162. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 163. Hulan Bio Influenza Drugs and Vaccines Product
Table 164. Hulan Bio Recent Developments/Updates
Table 165. Changchun Institute of Biological Corporation Information
Table 166. Changchun Institute of Biological Description and Business Overview
Table 167. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 168. Changchun Institute of Biological Influenza Drugs and Vaccines Product
Table 169. Changchun Institute of Biological Recent Developments/Updates
Table 170. Jiangsu GDK Corporation Information
Table 171. Jiangsu GDK Description and Business Overview
Table 172. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 173. Jiangsu GDK Influenza Drugs and Vaccines Product
Table 174. Jiangsu GDK Recent Developments/Updates
Table 175. Sinovac Corporation Information
Table 176. Sinovac Description and Business Overview
Table 177. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 178. Sinovac Influenza Drugs and Vaccines Product
Table 179. Sinovac Recent Developments/Updates
Table 180. Beike Bio Corporation Information
Table 181. Beike Bio Description and Business Overview
Table 182. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 183. Beike Bio Influenza Drugs and Vaccines Product
Table 184. Beike Bio Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Influenza Drugs and Vaccines Distributors List
Table 188. Influenza Drugs and Vaccines Customers List
Table 189. Influenza Drugs and Vaccines Market Trends
Table 190. Influenza Drugs and Vaccines Market Drivers
Table 191. Influenza Drugs and Vaccines Market Challenges
Table 192. Influenza Drugs and Vaccines Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Drugs and Vaccines
Figure 2. Global Influenza Drugs and Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Influenza Drugs and Vaccines Market Share by Type in 2022 & 2029
Figure 4. Influenza Drugs Product Picture
Figure 5. Influenza Vaccines Product Picture
Figure 6. Global Influenza Drugs and Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Influenza Drugs and Vaccines Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Influenza Drugs and Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Influenza Drugs and Vaccines Market Size (2018-2029) & (US$ Million)
Figure 13. Global Influenza Drugs and Vaccines Sales (2018-2029) & (Tons)
Figure 14. Global Influenza Drugs and Vaccines Average Price (US$/Kg) & (2018-2029)
Figure 15. Influenza Drugs and Vaccines Report Years Considered
Figure 16. Influenza Drugs and Vaccines Sales Share by Manufacturers in 2022
Figure 17. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Influenza Drugs and Vaccines Players: Market Share by Revenue in 2022
Figure 19. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Influenza Drugs and Vaccines Sales Market Share by Country (2018-2029)
Figure 22. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2018-2029)
Figure 26. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2018-2029)
Figure 27. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2018-2029)
Figure 34. China Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2018-2029)
Figure 45. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Influenza Drugs and Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Influenza Drugs and Vaccines by Type (2018-2029)
Figure 55. Global Revenue Market Share of Influenza Drugs and Vaccines by Type (2018-2029)
Figure 56. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2018-2029)
Figure 57. Global Sales Market Share of Influenza Drugs and Vaccines by Application (2018-2029)
Figure 58. Global Revenue Market Share of Influenza Drugs and Vaccines by Application (2018-2029)
Figure 59. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2018-2029)
Figure 60. Influenza Drugs and Vaccines Value Chain
Figure 61. Influenza Drugs and Vaccines Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed